Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hepatitis C virus (HCV) is a major cause of chronic liver disease. The World Health Organization has reported that 170 million people are chronically infected with HCV globally. The highest prevalence of HCV infection worldwide exists in Egypt (15%); 90% of infection among Egyptian patients is due to genotype 4

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera

NCT03882307

Hepatitis C, Chronic

UNKNOWN EARLY_PHASE1

Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers

NCT03254901

Hepatitis C

UNKNOWN

A Cross Sectional Observational Study on Relation Between Oral Manifestation and Hepatitis C in Egypt

NCT04812990

Hepatitis C Oral Manifestations in Egyptian Population

COMPLETED

Insulin Resistance Among Hepatitis C Infected Children

NCT07238530

This Study is to Assess Occurence of Insulin Resistance Among Hepatits C Infected Children Whether Thalassemic or Survivors of Childhood Malignancy

COMPLETED

History of Hepatitis C in Volunteer Blood Donors

NCT00001982

Hepatitis C

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis c

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

All patients will be subjected to: Baseline investigations, end of treatment investigations and 3 months after treatment investigations.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic HCV infection will be diagnosed based on positive testing for serum HCV RNA and anti-HCV Ab.
* Diagnosis of type 2 DM will depend on fasting level of serum glucose more than 126 mg/dl and/or serum level of HbA1c more than 6.5 % on oral hypoglycemic therapy.

Exclusion Criteria

* Chronic hepatitis due to causes other than HCV infection
* Coinfection with HBV infection
* Hepatocellular carcinoma
* Child C stage of liver cirrhosis.
* Patients with type I diabetes mellitus.
* Cardiopulmonary diseases.
* Major illness.
* Patient receiving corticosteroids.
* Patient refused consent.

Eligible Sex

ALL

Accepts Healthy Volunteers

No